# A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)

> **NCT00092651** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 1398 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** MK0653A, ezetimibe (+) simvastatin
- **DRUG:** Comparators: simvastatin and ezetimibe

## Key facts

- **NCT ID:** NCT00092651
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-09
- **Primary completion:** 2003-06
- **Final completion:** 2003-06
- **Target enrollment:** 1398 (ACTUAL)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00092651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00092651, "A Study of MK0653A (Ezetimibe (+) Simvastatin) in Patients With Hypercholesterolemia (0653A-038)". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT00092651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*